Articles By Anuja Singh

Can Novartis AG’s $3 Billion AI-Driven Oncology Bet Redefine Precision Breast Cancer Treatment and…

Key Highlights: AI-Led Drug Discovery Accelerates Target Identification and ValidationNovartis AG’s acquisition of SNV4818 from Synnovation Therapeutics, Inc.…

ByByAnuja Singh Mar 24, 2026
How Will Emerging Drug Pricing Policies Reshape the Global Biopharma Industry in the Near…

The global biopharmaceutical industry is entering a new policy-driven era as governments intensify efforts to control drug costs,…

ByByAnuja Singh Mar 6, 2026
Strategic Industry Release: How AI Companies Led Biopharma Innovation Through Major Collaborations in 2025

Artificial intelligence companies emerged as critical innovation partners for the global biopharmaceutical industry in 2025, reshaping how drugs…

ByByAnuja Singh Mar 6, 2026
AI in Life Sciences: A Multi-Billion Dollar Transformation Reshaping Drug Discovery and Healthcare

Artificial intelligence is rapidly becoming one of the most transformative forces in the life sciences industry. Global investment…

ByByAnuja Singh Mar 6, 2026
Strategic Industry Analysis: What the Biggest Biopharma Deals of 2025 Reveal About the Future…

The global biopharmaceutical industry experienced a powerful wave of strategic dealmaking in 2025 as major pharmaceutical companies accelerated…

ByByAnuja Singh Mar 6, 2026
EU Regulators Back CAMCEVI: A Key Step Toward Expanding Prostate Cancer Treatment Options

Foresee Pharmaceuticals has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of…

ByByAnuja Singh Mar 6, 2026
Image Not Found
Can Novartis AG’s $3 Billion AI-Driven Oncology Bet Redefine Precision Breast Cancer Treatment and…

Key Highlights: AI-Led Drug Discovery Accelerates Target Identification and ValidationNovartis AG’s acquisition of SNV4818 from Synnovation Therapeutics, Inc.…

ByByAnuja Singh Mar 24, 2026
How Will Emerging Drug Pricing Policies Reshape the Global Biopharma Industry in the Near…

The global biopharmaceutical industry is entering a new policy-driven era as governments intensify efforts to control drug costs,…

ByByAnuja Singh Mar 6, 2026
Strategic Industry Release: How AI Companies Led Biopharma Innovation Through Major Collaborations in 2025

Artificial intelligence companies emerged as critical innovation partners for the global biopharmaceutical industry in 2025, reshaping how drugs…

ByByAnuja Singh Mar 6, 2026
AI in Life Sciences: A Multi-Billion Dollar Transformation Reshaping Drug Discovery and Healthcare

Artificial intelligence is rapidly becoming one of the most transformative forces in the life sciences industry. Global investment…

ByByAnuja Singh Mar 6, 2026
Strategic Industry Analysis: What the Biggest Biopharma Deals of 2025 Reveal About the Future…

The global biopharmaceutical industry experienced a powerful wave of strategic dealmaking in 2025 as major pharmaceutical companies accelerated…

ByByAnuja Singh Mar 6, 2026
EU Regulators Back CAMCEVI: A Key Step Toward Expanding Prostate Cancer Treatment Options

Foresee Pharmaceuticals has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of…

ByByAnuja Singh Mar 6, 2026
Scroll to Top